ALPS

Alps Group Inc

There isn't enough reported data to score ALPS yet.

ALPS Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

ALPS's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

ALPS PE Valuation

ALPS has no meaningful PE right now: it lost money over the past year.

ALPS Forward outlook

There aren't enough analyst estimates for ALPS to show an outlook.

ALPS Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $1.18 on Nov 12.

There is not enough scenario data to assess ALPS's risk to reward.

ALPS Earnings Per Share

Q3 2024: $-0.51Q4 2024: $-0.83Q1 2025: $-1.52Q2 2025: $-2.54Q3 2025: $-3.64
Q3 2024: $-0.51Q4 2024: $-0.83Q1 2025: $-1.52Q2 2025: $-2.54Q3 2025: $-3.64
QuarterTTM EPSYoY
Q3 2025-$3.64-$3.13

ALPS lost $3.64 per share over the past year, and its loss has widened in each of the last four quarters.

ALPS Quarterly Revenue

Q4 2022: −$17MQ1 2023: $49MQ4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q1 2026: --
Q4 2022: −$17MQ1 2023: $49MQ4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q1 2026: --

ALPS's revenue is shrinking: $0 last quarter.

ALPS Free Cash Flow

Q4 2022: --Q1 2023: $47MQ4 2023: −$228,000Q1 2024: −$885,810Q2 2024: −$673,880Q3 2024: −$197,930Q4 2024: −$281,710Q1 2025: −$160,040Q2 2025: −$270,410Q3 2025: −$250,259Q1 2026: --
Q4 2022: --Q1 2023: $47MQ4 2023: −$228,000Q1 2024: −$885,810Q2 2024: −$673,880Q3 2024: −$197,930Q4 2024: −$281,710Q1 2025: −$160,040Q2 2025: −$270,410Q3 2025: −$250,259Q1 2026: --
QuarterFree cash flowYoY
Q3 2025-$250.3K-$52.3K
Q2 2025-$270.4K+$403.5K
Q1 2025-$160K+$725.8K
Q4 2024-$281.7K-$53.7K
Q1 2024-$885.8K-102%

ALPS has burned cash in almost every quarter: −$962,419 over the past year, against −$2M the year before.

ALPS Total Shares

Q4 2022: 11MQ4 2023: 1MQ1 2024: 1MQ2 2024: 1MQ3 2024: 1MQ4 2024: 1MQ1 2025: 922,995Q2 2025: 732,793Q3 2025: 703,520
Q4 2022: 11MQ4 2023: 1MQ1 2024: 1MQ2 2024: 1MQ3 2024: 1MQ4 2024: 1MQ1 2025: 922,995Q2 2025: 732,793Q3 2025: 703,520
PeriodChange %Net change
Quarterly-4%-29.3K shares
1 year-41%-498K shares

ALPS has 703,520 diluted shares, down 41% from a year ago, with $30M in buybacks over the past year.

ALPS Net Leverage

ALPS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ALPS Weekly Momentum

MetricValueStatus
RSI11.7Oversold
Stochastic33.6Neutral

ALPS's weekly RSI is 12 (oversold) and its Stochastic is 34 (neutral).

ALPS PE vs Healthcare Sector

ALPS has no meaningful PE right now: it lost money over the past year.

ALPS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.7031% below
20 week MA$1.9640% below
50 week MA$3.5066% below

ALPS is in a downtrend: it's below all three of its weekly moving averages, and 66% below its 50-week average.

ALPS Yearly ROI

YearStart priceEnd priceROI
2025$12.8$4.95-61%
2026 YTD$4.95$1.18-76%

ALPS has finished every year since 2025 lower, and it's down 76% so far in 2026.

Give your agent the market.

Get API key